Last A$0.11 AUD
Change Today -0.035 / -25.00%
Volume 20.7M
As of 2:10 AM 04/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John W. Holaday Ph.D.

Chief Executive Officer, Managing Director, Chief Scientific Officer, President of US Operations, Director and Member of Remuneration Committee, QRxPharma Limited
AgeTotal Calculated CompensationThis person is connected to 37 board members in 8 different organizations across 13 different industries.

See Board Relationships
As of Fiscal Year 2013


Dr. John W. Holaday, PhD has been the Chief Executive Officer and Managing Director of QRxPharma Pty Ltd. since April 2007 and serves as its Chief Scientific Officer. Dr. Holaday serves as President of US operations at QRxPharma Pty Ltd. He serves as an Advisor at QBit, LLC and served an Scientific Advisor at Accelovance, Inc. He served as the Chief Executive Officer of EntreMed Inc. from August 1992 to 2002, Chairman from 1995 to January 2003 and also served as its ...

Read Full Background

Corporate Headquarters*

100 Walker Street
North Sydney, New South Wales 2060


Phone: 61 2 9492 8021
Fax: 61 2 8920 0314

Board Members Memberships*

Former Director
Chief Executive Officer, Managing Director, Chief Scientific Officer, President of US Operations, Director and Member of Remuneration Committee
Former Director
Former Scientific Advisor and Board Member
Former Director
Co-Founder and Chairman of the Board of Directors
Former Chairman of the Board, Chief Executive Officer and President
Former Director
Former Non-Executive Director and Member of Remuneration & Audit Committee


Unknown/Other Education
University of California
Doctorate 1977
University of California-San Francisco
PhD 1977
University of California-San Francisco
University of California, San Francisco School of Medicine
MS 1969
University Of Alabama
BS 1966
University Of Alabama

Other Affiliations*

Annual Compensation*

Total Annual CompensationA$401,205

Stock Options*

Exercisable Options1,438,785
Unexercisable Options466,667
Total Number of Options1,905,452

Total Compensation*

Total Annual Cash CompensationA$401,205
Total Short Term CompensationA$401,205
Total Calculated CompensationA$624,990
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
QRX:AU A$0.11 AUD -0.035


There is no Competitor Compensation data available.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact QRXPHARMA LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at